Dermal fillers like Juvederm have long been used by plastic surgeons to restore volume to sunken or hollow cheeks. Despite this, dermal fillers have yet to receive FDA-approval for cheek augmentation.
But this might soon change.
Earlier this month, the FDA’s General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee unanimously agreed that Juvederm is both a safe and effective treatment for volume deficient areas in the mid face.
Allergan’s (the maker of Juvederm) Executive VP of Research and Development and Chief Scientific Officer, Dr. Scott Whitcup, had this to say about the pending FDA-approval:
“Allergan is committed to working with the FDA as they continue their review of our PMA for Juvederm Voluma XC, with the goal of providing consumers with the first treatment option that has been specifically developed to help restore cheek volume that has been lost over time.”
Though the advisory’s recommendation isn’t binding, it will certainly hold weight when the FDA makes its final decision. If approved, Juvederm will be the first of its kind for cheek augmentation. Allergan hopes to launch Juvederm Voluma XC by the end of this year.
In addition to cheek augmentation, Juvederm is a versatile anti-aging treatment that can be used to:
The results of Juvederm typically last between four and six months. Repeat treatments will be necessary to maintain results. If you’re considering Juvederm, it’s best to schedule a consultation with a qualified plastic surgeon.
“Patient care was incredible! We are so very happy our child was referred to Dr. Will. We appreciate the attentiveness given to his medical condition. Will highly recommend to others.”Read More Reviews